Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Bone marrow spatial architecture predicts response duration in smoldering multiple myeloma patients receiving checkpoint inhibitor therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

JAJon C. AsterDLDavid Liu

Discussion

Loading...

Member takes

Overview

Analysis shows that spatial organization impacts progression-free survival in smoldering multiple myeloma patients, suggesting new treatment strategies.

Key Points

  • Early analysis found that bone marrow spatial architecture associates with treatment duration.
  • After 38 months, the median progression-free survival was 33.8 months in patients receiving nivolumab.
  • Assessment utilized imaging mass cytometry and analyzed cellular neighborhoods in bone marrow biopsies.
  • Insights suggest that strategic spatial organization of immune cells could inform future treatment approaches.

Cite This Study

Aster et al. (2025) studied this question.

synapsesocial.com/papers/69362f484fa91c937236d689https://doi.org/10.1182/blood-2025-5702
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Spatial proteomics of the bone marrow reveals distinct Tumor–Immune niches in smoldering and relapsed myeloma and their remodeling in response to bispecific antibody and CAR-T therapy2025
  2. 2Spatial biomarkers of CAR-T treatment response in relapsed refractory multiple myeloma2025
  3. 3Spatially resolved transcriptomics reveals immunosuppressive niches and clonal diversity in extramedullary disease in multiple myeloma refractory to immunotherapy2025
  4. 4Highly multiplexed imaging recovers immune and metabolic niches in multiple myeloma associated with disease progression and bone involvement2025 · 1 citations
  5. 5Spatial single-cell multiomics of the bone marrow microenvironment in NPM1-mutant Acute Myeloid Leukemia2025